HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiziana Braccini Selected Research

batimastat (BB 94)

7/2020Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
12/2014Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiziana Braccini Research Topics

Disease

2Brain Injuries (Brain Injury)
07/2020 - 12/2014
2Meningococcal Meningitis
07/2020 - 12/2014
2Infections
12/2014 - 09/2009
1Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
07/2020
1Hemorrhage
12/2014
1Meningitis
09/2009

Drug/Important Bio-Agent (IBA)

2batimastat (BB 94)IBA
07/2020 - 12/2014
2Matrix Metalloproteinases (MMPs)IBA
07/2020 - 12/2014
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
07/2020
1Matrix Metalloproteinase InhibitorsIBA
07/2020
1Tetracycline (Achromycin)FDA LinkGeneric
07/2020
1Neuroprotective AgentsIBA
07/2020
1Doxycycline (Periostat)FDA LinkGeneric
07/2020
1Biomarkers (Surrogate Marker)IBA
12/2014
1Glutathione (Reduced Glutathione)IBA
09/2009
1AntioxidantsIBA
09/2009
1Glutamic Acid (Glutamate)FDA Link
09/2009

Therapy/Procedure

1Therapeutics
07/2020